Stefan Oschmann

Chief Executive Officer at Merck KGaA

Stefan Oschmann

Stefan Oschmann

Chief Executive Officer at Merck KGaA

Overview
Career Highlights

Merck KGaA
Millipore SpA
Merck Pharma GmbH

RelSci Relationships

374

Number of Boards

6

Birthday

07/1957

Age

63

Relationships
RelSci Relationships are individuals Stefan Oschmann likely has professional access to. A relationship does not necessarily indicate a personal connection.

Chief Executive Officer of Consumer Health at Merck KGaA

Relationship likelihood: Strong

Future Chief Executive Officer at Merck KGaA (Effective 04/2021)

Relationship likelihood: Strong

Chief Executive Officer, Performance Materials at Merck KGaA

Relationship likelihood: Strong

Chief Financial Officer at Merck KGaA

Relationship likelihood: Strong

Global Chief of Staff & Head-Strategy Realization Office at Merck KGaA

Relationship likelihood: Strong

Global Head of Healthcare Legal at Merck KGaA

Relationship likelihood: Strong

Global Head of Healthcare Human Resources at Merck KGaA

Relationship likelihood: Strong

Global Head of Healthcare Controlling at Merck KGaA

Relationship likelihood: Strong

Chief Medical Officer at Flagship Pioneering

Relationship likelihood: Strong

Chief Executive Officer at Kymab Ltd.

Relationship likelihood: Strong

Paths to Stefan Oschmann
Potential Connections via
Relationship Science
You
Stefan Oschmann
Chief Executive Officer at Merck KGaA
Education
PhD

Ludwig-Maximilians-Universität München is a premier academic and research institutions.

Career History
Chief Executive Officer
Current - 2021

Merck KGaA is a science and technology company, which engages in the manufacture of pharmaceutical and chemical products. It operates through the following sectors: Healthcare, Life Science, Performance Materials and Corporate & Other. The Healthcare sector discovers, develops, and produces prescription medicines used to treat cancer, multiple sclerosis, and infertility. The Life Science sector provides scientists with laboratory materials, technologies, and services. The Performance Materials sector offers specialty chemicals and materials for demanding applications. The firm offers pharma and biopharma manufacturing, pharmaceutical research, pharma quality control, and government and academic research services. The company was founded by Friedrich Jacob Merck in 1668 and is headquartered in Darmstadt, Germany.

Chief Executive Officer
Current

Millipore SpA, part of Merck KGaA, is a company headquartered in Vimodrone, Italy. The firm provides Industrial instruments for measurement. Stefan Oschmann is the current CEO of the firm.

Tenure Unconfirmed

Merck & Co., Inc. , d.b.a. Merck Sharp & Dohme, MSD outside the United States and Canada, is an American pharmaceutical company and is one of the largest pharmaceutical companies in the world.

Boards & Committees
Chairman, Executive Board
Current - 2021

Merck KGaA is a science and technology company, which engages in the manufacture of pharmaceutical and chemical products. It operates through the following sectors: Healthcare, Life Science, Performance Materials and Corporate & Other. The Healthcare sector discovers, develops, and produces prescription medicines used to treat cancer, multiple sclerosis, and infertility. The Life Science sector provides scientists with laboratory materials, technologies, and services. The Performance Materials sector offers specialty chemicals and materials for demanding applications. The firm offers pharma and biopharma manufacturing, pharmaceutical research, pharma quality control, and government and academic research services. The company was founded by Friedrich Jacob Merck in 1668 and is headquartered in Darmstadt, Germany.

Member-Supervisory Board
2018 - Current

Springer Nature AG & Co. KGaA engages in the publishing business. Its activities also include the development, acquisition, and marketing of information systems and related products. In addition, the firm trades in licenses as well as other rights to media and information systems. The company is headquartered in Berlin, Germany.

Member-Supervisory Board
Prior

Springer Nature Deutschland GmbH publishes scientific books, periodicals, and journals that focus on scientific and technical information. It also offers business services, seminars, trade fairs, conferences, as well as online publishing. The company was founded by Julius Springer on May 10, 1842 and is headquartered in Berlin, Germany.

President
Current

The European Federation of Pharmaceutical Industries and Associations (EFPIA) is a Brussels-based trade association founded in 1978 representing the research-based pharmaceutical industry operating in Europe.

Member, Executive Committee
Current
This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by Stefan Oschmann. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of Stefan Oschmann's profile does not indicate a business or promotional relationship of any kind between RelSci and Stefan Oschmann.